FDA Deems UVA Filter Ecamsule Eligible For Monograph, Seeks Data
This article was originally published in The Rose Sheet
Executive Summary
FDA's recent decision that the breakthrough UVA filtering ingredient ecamsule is "eligible for inclusion" in the OTC sunscreen drug monograph pending a safety and efficacy evaluation offers innovators more flexibility and could level the playing field among competing U.S. manufacturers